• Contact
  • Login
  • Contact
  • Login
  • TTM2

  • Menu
  • Contact
  • Login
  • About the study
    • History
    • Who are we
  • News
  • Documents
  • Sites
  • Partners
  • Substudies

Formal Interim analysis

04 October 2019

Today the Data Safety Monitoring Committee (DSMC) gave the recommendation to continue randomisation as planned. Their analysis is based on the 1200 randomisations up until August 2019. This is the only planned formal interim analysis in the trial. With 1520 participants randomised today and 380 to go we are anticipating a completion date in the beginning of 2020. 

The letter from the DSMC can be found here: https://ttm2trial.org/sites/default/files/document_items/ttm2%20dsmc%20letter%20interim%20analysis.pdf

News

Past 500

15 January 2019

Newsletter Dec - 12

12 December 2018

Screening Log

12 December 2018

Inclusion update (Nov 19) - 332 participants

19 November 2018

Neurofilament article in JAMA Neurology

30 October 2018

Inclusion update (Oct 25) - 267 participants,

25 October 2018

Neuroprognostication videos

17 September 2018

Site inclusion update

04 September 2018

August Update - 192 participants

29 August 2018

eCRF going live and some temporary procedures.

04 May 2018

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »

Helsingborg Hospital 
Anaesthesiology and Intensive Care 
Charlotte Yhlens gata 10
251 87 Helsingborg, Sweden
ttm2@ttm2trial.org

Skåne University Hospital
Center for Cardiac Arrest
Barngatan 2A, Practicum
22185 Lund, Sweden
ttm2@ttm2trial.org